Kawasaki time

Pediatric Annals

Volumn 38, Issue 2, 2009, Pages 67-68

  Shulman, Stanford T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; STAPHYLOCOCCUS TOXIN;

ARTERY INTIMA PROLIFERATION; BACTERIAL INFECTION; CAUSAL ATTRIBUTION; CHILD; CORONARY ARTERY DISEASE; EDITORIAL; FATALITY; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MUCOCUTANEOUS LYMPH NODE SYNDROME; RESPIRATORY TRACT DISEASE; VIRUS INFECTION; VIRUS LIKE AGENT; GENETICS; IMMUNOLOGY; PATHOPHYSIOLOGY;

HUMANS; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 63049119369     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20090201-03     Document Type: Editorial

References (4)

1. Rowley AH, Baker SC, Shulman ST, et al. RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS ONE. 2008;3(2):e1582.
2. Rowley AH, Baker SC, Orenstein JM, Shulman ST. Searching for the cause of Kawasaki disease - cytoplasmic inclusion bodies provide new insight. Nat Rev Microbiol. 2008;6(5):394-401.
3. Onouchi Y, Tamari M, Takahashi A, et al: A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12. J Hum Genet. 2007;52(2):179-190.
4. Burgner D, Davila S, Breunis WB, et al. A Genome-Wide Association Study Identifi es Novel and Functionally Related Susceptibility Loci for Kawasaki Disease. PLoS Genet. 2009; 5:e1000319.